Hypromeloza

Quick links to important sections

Hypromeloza

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hypromeloza

Quick Facts

Property Description
Active ingredient Hypromellose (Hydroxypropyl Methylcellulose)
Form Ophthalmic solution or gel
Pharmacological class Ophthalmic Lubricant / Artificial Tears
Common use Symptomatic relief of ocular dryness
Origin Semisynthetic cellulose polymer

Defining Hypromeloza: The Identity and Class of the Medicine

Hypromeloza is the medicinal name used for preparations containing the active substance Hypromellose, which is chemically defined as Hydroxypropyl Methylcellulose (HPMC). This compound is classified within the pharmaceutical category of Ophthalmic Lubricants and Irrigations, a high-level grouping commonly referred to as Artificial Tears. Hypromellose is not a natural substance but a semisynthetic polymer, meaning it is chemically derived from cellulose. The international classification system recognizes Hypromellose as a primary ingredient in non-prescription tear substitutes.

Composition, Forms, and Its Non-Pharmacological Role

Hypromeloza products typically utilize Hypromellose as the single-active ingredient and are predominantly available as an ophthalmic solution (eye drops) or a more viscous ophthalmic gel. The medication is an aqueous-based preparation. The product's action is entirely non-pharmacological, relying instead on the physical property of Hypromellose to increase the fluid's viscosity upon ocular application. Hydroxypropyl Methylcellulose formulations are clinically recognized for their low irritation potential and effective viscoelasticity. This means the ingredient acts gently on the eye's surface while effectively prolonging the moisturizing effect.

General Purpose: What Hypromeloza is Designed to Relieve

The general purpose of Hypromeloza is to create a temporary, smooth protective film and provide essential lubrication to the cornea and conjunctiva. This action reliably substitutes for the deficient or absent aqueous layer of the tear film, delivering a consistent moisturizing effect. A typical scenario for its use is providing relief from ocular surface dryness caused by environmental factors. By stabilizing the ocular surface, it is designed to relieve the physical symptoms of dryness and irritation resulting from insufficient tear creation.

What side effects are possible with Hypromeloza?

Possible Side Effects and Safety Information

The safety profile for Hypromeloza (Hydroxypropyl Methylcellulose) ophthalmic preparations is characterized by a low incidence of adverse reactions, which are officially documented primarily within the Eye disorders system-organ class. This reflects the medicine's non-pharmacological action and the negligible systemic exposure of the active substance upon ocular administration.

Officially documented adverse reactions are typically local and transient (short-lived) in nature, occurring most often immediately following application. These include sensations such as transient mild stinging, temporary blurred vision, eye irritation, and a foreign body sensation in eyes.

Most reported adverse reactions are classified as Frequency Not Known in regulatory documents, indicating that their exact occurrence rate cannot be estimated from the available data gathered primarily through post-marketing surveillance.


Safety Considerations

Safety Domain Regulatory Statement
Serious Reactions Contraindication for individuals with known hypersensitivity to any component. Persistence or worsening of symptoms is a marker requiring cessation.
Special Populations No effects are anticipated on pregnancy, lactation, or fertility due to the active substance being pharmacologically inert and having negligible systemic absorption.
Restrictions Caution is advised regarding driving or operating machinery due to the potential for transient blurring of vision. Formulas containing preservatives often require soft contact lenses to be removed prior to instillation.

The fundamental safety characteristic is that the negligible systemic exposure of the active substance minimizes the risk of non-ocular safety concerns, ensuring the profile is dominated by effects restricted to the ocular surface.

Overdose and Emergency Response

Overdose and When to Seek Help

Documented Overdose Profile

Official government regulatory documents classify the overdose risk for Hypromeloza (Hypromellose) as non-toxic, stemming from the preparation's inert characteristics and the drug's negligible systemic absorption. Due to this non-pharmacological action, regulatory labeling explicitly states that no toxic effects are expected following an ocular overdose.

Overdose presentations are generally classified as “Not applicable” or having “No known reactions” in authoritative regulatory texts. This non-toxic designation applies not only to topical overuse but also to exposure-related factors, confirming that no toxic effects are anticipated in the event of accidental ingestion of the contents of a single container. Consequently, no specific antidote is known or required, and regulatory documentation does not mandate specialized monitoring protocols.

Mandated Emergency Action

The central component of the regulatory emergency response is the protocol for accidental ingestion. Government authorities explicitly require an individual to seek immediate medical help or contact a poison control center right away if the ophthalmic solution has been swallowed. This required action is a necessary precaution stipulated in official labeling for accidental ingestion of the product, even while the substance maintains its official non-systemic toxicity profile.

Therapeutic Uses of Hypromeloza

What Hypromeloza Treats: Main Uses and Benefits

Hypromeloza is classified as an ophthalmic lubricant. It is applied in areas where short-term symptomatic assistance is needed to address surface discomfort and contribute to easing the overall symptom load.

The medication is commonly used to provide symptomatic relief in conditions characterized by periods of heightened symptoms such as Dry Eye Disease, Keratoconjunctivitis sicca, and conditions where functional stability becomes affected by surface irritation. It addresses the sensory discomfort stemming from tear film deficiency, specifically targeting symptoms related to physical discomfort like burning, stinging, and the unpleasant gritty sensation.

“It is generally a supportive therapy for mild-to-moderate chronic cases, offering essential surface lubrication and protection.”

It is also applied in scenarios where additional management of discomfort is required due to temporary factors such as environmental stress, prolonged visual concentration (screen use), post-operative eye care, and when using hard contact lenses, providing supportive relief that may assist with maintaining functional stability.

Quick Fact: Relief for Dry Eye Discomfort
Primary Goal Provides support that helps ease the overall symptom burden by moisturizing the eye surface.
Target Symptoms Burning, stinging, gritty sensation, and friction-related scratchiness.
Typical Context Mild-to-moderate DED, environmental dryness, and post-surgical lubrication needs.

Eligibility and Restrictions for Use

Hypromeloza (Hypromellose ophthalmic solution) eligibility is defined by regulatory bodies based on patient sensitivity and life stage, with minimal systemic restrictions due to its inert, non-systemic nature.

Eligibility Scope

Classification Population/Condition Regulatory Status
Absolute Contraindication Hypersensitivity to Hypromellose or any excipients Must not be used
Allowed Populations Adults, Children, and The Elderly Use is established and approved
Conditional Use Pregnant Women Use is restricted; advised only when considered essential by a physician
Conditional Use Soft Contact Lens Wearers Must not be used while wearing lenses (if formula contains a preservative)
Use with Caution Patients with a Compromised Cornea Should be used with caution

Population-Specific Notes

  • Pediatric Use: The product is officially approved for use in children and infants, though some non-preserved formulas may carry a label stating safety and efficacy have not been established in those under 18 years of age.
  • Lactation: Use during breastfeeding is generally considered acceptable, as systemic exposure to the nursing mother is negligible, and the compound is pharmacologically inert.
  • Organ Function: No specific restrictions are documented for patients with renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Hypromeloza (Hypromellose) is defined by its physical mechanism of action as a topical ophthalmic lubricant and its negligible systemic absorption. This significantly restricts the potential for systemic drug interactions.

Pharmacokinetic and Systemic Interactions

Official regulatory documents confirm that because systemic exposure to Hypromellose is considered negligible, the substance is not involved in major pharmacokinetic interactions. Therefore, no formal contraindications, exposure modifications (such as altered AUC or Cmax), or interactions with metabolic enzymes (like CYP450) or drug transporters are documented with oral or parenteral medicines.

Local Pharmacodynamic Interactions

The only officially documented interaction is a local pharmacodynamic effect on the eye surface with other topical ophthalmic medications. Due to the high viscosity of Hypromeloza, its co-administration with other eye drops or ointments is documented to prolong the contact time of the other product.

Administration Timing Rule

To manage this physical interaction and ensure the efficacy of co-administered medicines, official labeling specifies a procedural requirement: an administration interval of 5 to 15 minutes must be observed between the application of Hypromeloza and any other topical ocular preparation. This is required for sequential administration to prevent the previous drug from being washed out.

Mechanism of Action

Hypromellose (Hypromeloza, also known as hydroxypropyl methylcellulose or HPMC) exerts its primary mechanism of action through physicochemical properties rather than biochemical pathways. As a high molecular weight, non-ionic cellulose ether polymer, it functions primarily as a viscoelastic agent.

The polymer forms a mucoadhesive matrix by interacting with the mucin layer present on the corneal and conjunctival epithelial cell surfaces . This interaction type is characterized by physical adherence, which increases the residence time of the applied solution on the ocular surface. The increase in residence time physically modulates the viscoelasticity and thickness of the pre-corneal tear film, thereby stabilizing the film's structure. This system-level physiological consequence is mechanistically quantified by a demonstrable increase in Tear Film Breakup Time (TFBUT). The action is one of surface dynamics modulation, maintaining the integrity of the polymer layer at the ocular-air interface.

Dosage and Administration Information

Hypromellose is administered via the topical ophthalmic route, restricted to the surface of the eye. The usage pattern is determined by the continuous need for ocular lubrication rather than a fixed systemic schedule, which allows the product to be used as a long-term supportive regimen. Dosing regimens are defined across a standard scope of use.


Administration Scope and Frequency

Feature Specification
Route of Administration Topical Ophthalmic only (into the affected eye).
Dosing Schedule Instillation of one or two drops per application.
Frequency Pattern Applied multiple times daily (e.g., three to five times daily) or as-needed, guided by individual lubrication requirements.
Age-Group Rules The standard dosage applies to adults, children, and the elderly; no specific adjustments are typically required due to the negligible systemic absorption.

Special Procedural Conditions

Prescribing information includes specific instructions critical for proper administration. To maintain product integrity, users must not touch the dropper tip to the eye or any other surface. If the preparation contains preservatives, soft contact lenses must be removed before instillation and should not be reinserted for at least 15 minutes afterward. When Hypromellose is used concurrently with other topical ophthalmic products, a time interval of 5 to 15 minutes must be observed between the separate applications. The use protocol establishes a framework centered on localized delivery and symptom-driven frequency, defining how often and under what constraints the drops are to be used.

Recent Clinical Evidence

Hypromeloza: Recent Clinical Evidence


Hypromeloza (Hydroxypropyl Methylcellulose or HPMC) is a polymer studied for its role in ophthalmic solutions, primarily due to its viscosity and mucoadhesive properties. It functions as a lubricant and wetting agent, intended to mimic the protective action of natural tears.

Clinical Applications and Study Focus

Research on hypromeloza primarily focuses on its use in managing symptoms of dry eye syndrome (keratoconjunctivitis sicca). Clinical trials have investigated its capacity to stabilize the tear film and prolong the residence time of the solution on the ocular surface. Studies often assess the effect of hypromeloza-containing formulations on key ophthalmic measures:

  • Ocular Surface Integrity: Evaluated using metrics like corneal and conjunctival staining scores.
  • Tear Film Stability: Assessed via non-invasive tear film breakup time (TBUT) measurements.
  • Symptom Relief: Measured through patient-reported visual analog scale (VAS) scores for discomfort, burning, and dryness.

Findings on Efficacy and Safety

Comparative studies have evaluated hypromeloza against placebo and other common artificial tear components, such as carboxymethylcellulose (CMC) and polyethylene glycol (PEG). Findings suggest that hypromeloza-based formulations may be associated with improved tear film stability and reduced ocular discomfort compared to baseline or non-treated eyes.

The safety profile of hypromeloza is generally favorable. Studies indicate that it is well-tolerated when used topically in the eye, with minimal reports of severe adverse events. The most common minor effects reported are transient blurring of vision or mild ocular irritation upon application, likely attributable to the viscosity of the formulation rather than the active ingredient itself. Research confirms its utility as a protective vehicle in ophthalmology.

Frequently Asked Questions (FAQ)

Common questions about Hypromeloza (FAQ)


Q: Does Hypromeloza contain any preservatives?

Hypromeloza is available in different product formulations. Official regulatory labeling shows that some products contain a preservative as part of the inactive ingredients, while other formulations are sold as preservative-free. The specific list of inactive ingredients for any product, including any preservative used, can be found on that product's official labeling.


Q: Can Hypromeloza be used with contact lenses?

Official instructions generally require that if the product contains a preservative, soft contact lenses must be removed before you apply the drops. They should not be reinserted for a specific time interval, which is often 15 minutes, to prevent irritation or staining. Some regulatory documents indicate that the product is suitable for moistening hard contact lenses.


Q: Is Hypromeloza suitable for use during pregnancy or breastfeeding?

Regulatory documents indicate that use during pregnancy or breastfeeding is generally not expected to cause issues. This is because Hypromeloza is a non-systemic product, meaning only a negligible amount of the active substance is absorbed into the body. However, official information advises that it should be used only when considered necessary by a healthcare provider.


Q: What is the difference between Hypromeloza and carboxymethylcellulose drops?

Both Hypromeloza and carboxymethylcellulose are classified as ophthalmic lubricants used as artificial tears. Studies and official information suggest that the effectiveness and safety of Hypromeloza are generally comparable to other artificial tear preparations. Regulatory documents do not contain specific claims about one being superior to the other.


Q: Can using Hypromeloza too often cause any problems?

Hypromeloza is intended to be used multiple times daily or as needed to address eye dryness, based on lubrication requirements. Regulatory labeling advises that if eye irritation persists, worsens, or lasts longer than 72 hours, stopping use and consulting a physician is advised.


Q: Does Hypromeloza affect driving ability?

Official regulatory documents advise exercising caution when performing activities that require clear vision, such as driving or operating machinery. This warning is due to the potential for Hypromeloza to cause a temporary blurring of vision immediately following application, which should quickly clear.


Q: Can Hypromeloza affect eye pressure readings?

Hypromeloza is classified as a non-pharmacological lubricant that functions entirely on the eye's surface, with negligible systemic absorption. Due to its inert nature and local action, regulatory documents do not specifically list an effect on routine intraocular pressure (IOP) readings from the topical drop formulation.


Q: How long after opening should I discard Hypromeloza drops?

Official storage rules define the discard date to prevent contamination. Multi-dose bottles of Hypromeloza must be discarded 28 days or one month after the date of first opening, even if solution remains. Single-dose containers must be discarded immediately after use.


Q: Can children use Hypromeloza drops?

Official regulatory documents state that the standard dosage is approved for use in adults, children, and the elderly. Use in children has not been shown to cause different side effects or problems than in adults, though some non-preserved formulas may have specific age rules.


Q: What does 'Hypromeloza 0.3%' refer to?

The concentration noted on the label, such as '0.3%', refers to the concentration (weight/volume) of the active ingredient, Hypromellose, contained within the ophthalmic solution. Different formulations may be available in different concentrations.


Q: Are there known ingredients in Hypromeloza that cause allergic reactions?

Hypromeloza products are officially contraindicated (must not be used) by individuals with a known hypersensitivity or allergy to any component in the product, including the active ingredient or the inactive ingredients (excipients). Some reported side effects are consistent with local hypersensitivity.


Q: Why is Hypromeloza sometimes called HPMC?

HPMC is an abbreviation commonly used in regulatory and scientific contexts for the chemical name of the active substance: Hydroxypropyl Methylcellulose. Hypromeloza is the registered medicine name for preparations containing Hypromellose.


Q: Can Hypromeloza cause my eyelids to become sticky?

Yes, official regulatory documents list the potential for temporary side effects such as stickiness or matting of the eyelashes upon application. This effect is usually transient (short-lived) and related to the viscosity of the solution.


Q: Is Hypromeloza a lubricant or a tear stimulant?

Hypromeloza is officially classified as an Ophthalmic Lubricant or Artificial Tear. It acts by stabilizing the tear film through its physical properties, creating a protective layer. It is not classified as a pharmacological tear stimulant that causes the body to produce more natural tears.


Q: What are the common storage conditions described for Hypromeloza?

Official storage rules require the drops to be stored at room temperature, typically below 25 C (77 F). The container must be kept tightly closed, protected from light, and must not be frozen to ensure product stability.


Q: Can Hypromeloza be used by people with sensitive eyes?

Regulatory documents acknowledge that Hypromeloza may cause temporary mild eye irritation. For individuals who experience sensitivity reactions to common additives, preservative-free formulations of the drops are available.


Q: What should I do if I accidentally swallow a small amount of the eye drop solution?

If the eye drop solution is accidentally swallowed, official labeling contains an advisory to seek medical help or contact a Poison Control Center. This is a standard advisory for many topical preparations.

How should Hypromeloza be stored and disposed of?

How to Store and Dispose of Hypromellose Ophthalmic Solution

Official regulatory documents define strict conditions for the storage and disposal of Hypromellose solution to ensure stability and public safety.

Mandatory Storage Requirements

Condition Regulatory Rule
Temperature Store at room temperature, typically below 25 C (77 F). Do not freeze and keep away from heat.
Protection Keep the container tightly closed and store away from light and moisture.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

To prevent contamination, multi-dose bottles must be discarded after 28 days or 1 month of first opening. Unit-dose containers must be discarded immediately after use. Expired or unused medicine must not be thrown away via wastewater or household waste; individuals are directed to ask a pharmacist for the proper method of disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hypromeloza found in:

A-Z Index: